Supplementary Methods

Reagents
Fibronectin, BSA and tamoxifen (4-OHT) were from Sigma (St. Louis, MO) and SDF1alpha from PeproTech (Rocky Hill, NJ). For flow cytometry, FITC conjugated antimouse JAM-C from Abcam, Cambridge, MA was used. 7-AAD and FITC anti-ratIgG2 were from BD Biosciences. APC conjugated anti-mouse CD31 (clone 390) and FITC anti-VE-Cadherin (clone BV13) were from eBioscience, whereas monoclonal antibody (mAb) Gi11 against human JAM-C was described (1) . D-Luciferin Potassium Salt for in vivo imaging of luciferase activity was bought from Caliper Life Sciences (Hopkinton, MA). Tissue melanoma microarrays for immunohistochemistry were bought from US Biomax (Rockville, MD). Mouse VCAM-1-Fc, mouse JAM-C-Fc and human JAM-C-Fc were from R&D systems (Minneapolis, MN). Recombinant soluble mouse JAM-C (smJAM-C) was produced as a 6xHis-tagged protein in Schneider Drosophila S2 cells (Invitrogen) as previously described (2) . Control 6xHis peptide was purchased from Covance Research Products.
Generation of JAM-C conditional knockout mice
Mouse JAM-C gene is located on chromosome 9 and has 9 exons. In order to design a knockout construct we chose a targeting strategy of deletion of exon 1 which contains an ATG start codon. A 760 bp fragment of the JAM-C gene containing exon 1 and 560 bp of the promoter region was flanked by loxP sites for tissue specific deletion with Cre recombinase, as well as 6.4 Kb 5' long and 3 Kb 3' short arms for homologous recombination. Targeting vector ploxPFRTPGKneoFRT (kindly provided by Dr. G. Schütz, DKFZ, Heidelberg, Germany) also contained the neomycin resistance cassette flanked by frt sites for Flp mediated deletion. Electroporated and G418 selected embryonic stem cell clones were analyzed by southern blot using 473 bp Xba I/Nde I fragment as 5' probe to distinguish wt (14639 bp) and recombined (6420 bp) DNA cut with Spe I. The targeted ES cells were injected into blastocysts and chimeric mice were crossed with C57BL/6 to select for germ line transmission.
Positive mice were crossed with an flp-deleter mouse line, resulting in a wt/flox mouse.
In order to generate complete JAM-C null mice, JAM-C wt/flox mice were crossed with EIIa-Cre deleter mice (Jackson Laboratories), resulting in generation of heterozygous mice. JAM-C flox/flox mice were in a mixed 129:B6 background, whereas heterozygous (+/-) mice were kept in a mixed 129:B6 background as well as were backcrossed into the C57BL/6 background for 7 generations. By intercrossing JAM-C+/-mice, the percentages of JAM-C+/+, +/-and -/-mice at birth were 31%, 52% and 17%, respectively, i.e. JAM-C-deficient mice were born at almost Mendelian frequency. A high degree of pre-wean mortality of JAM-C-/-mice was observed. In particular, the numbers of JAM-C+/+, +/-and -/-mice at weaning (around postnatal day 22) were 27%, 67% and 6%, respectively. In addition, male KO mice surviving to adulthood were infertile similar to a previous report (3) . 
Isolation of total RNA and real time PCR analysis
Total RNA was isolated using the RNAeasy RNA extraction kit (Qiagen) and
NucleoSpin RNAII (Macherey-Nagel), followed by DNAse I treatment with TURBO DNA-free kit (Ambion). For cDNA generation with ImProm-II reverse transcriptase and random primers (Promega) or RevertAidH (Fermentas), 100-250 ng of total RNA was used. The cDNA samples were diluted 1:10 with ddH2O and subjected to realtime PCR analysis using QuantiTech SYBR Green Detection System (Qiagen) or 
Western blot analysis
B16 cells were lysed in RIPA buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.25% Na-deoxycholate, 0.1% SDS, 25 mM NaF, 1 mM sodium orthovanadate, and protease inhibitors) and 20-50 µg of protein was loaded and separated on 4-12% SDS gels (NUPAGE, Invitrogen), followed by 2 h transfer at 
Immunohistochemistry of human lungs
We performed immunohistochemistry from melanoma lung metastases. Sections 
Supplementary figure 8
Mice were evaluated for metastasis by in vivo imaging of luciferase activity after intraperitoneal injection of D-luciferin using a pitch-black chamber with a cooled CCD camera (Xenogen). Representative images from a WT and a JAM-C-/-mouse are shown.
Supplementary figure 9
WT mice receiving i.v. administration of B16 melanoma cells were treated with either soluble mouse JAM-C or control peptide and 21 days after B16 injection, mice were sacrificed, lungs were removed and sections were stained with hematoxylin and eosin. Soluble JAM-C treatment decreased substantially melanoma lung metastasis. 
JAM-C control
